These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12509709)

  • 21. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
    Slostad J; Stein QP; Flanagan JD; Hansen KA
    Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New cystic fibrosis genetic tests bring hope and dilemmas.
    Arnold C
    Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
    [No Abstract]   [Full Text] [Related]  

  • 24. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): implications for genetic testing.
    Moya-Quiles MR; Mondéjar-López P; Pastor-Vivero MD; González-Gallego I; Juan-Fita MJ; Egea-Mellado JM; Carbonell P; Casals T; Fernández-Sánchez A; Sánchez-Solís M; Glover G
    Clin Genet; 2009 Dec; 76(6):577-9. PubMed ID: 19845690
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of CFTR function in native epithelia for the diagnosis of cystic fibrosis.
    Barreto C; Mall M; Amaral MD
    Pediatr Pulmonol Suppl; 2004; 26():243. PubMed ID: 15029663
    [No Abstract]   [Full Text] [Related]  

  • 27. Dynamic modification strategy of the Israeli prenatal carrier screening protocol: inclusion of the oriental Jewish group to the cystic fibrosis panel-update.
    Reish O; Shohat M; Magal N; Pesso R; Borochowitz ZU; Adir V; Karpati M; Shimshoni DC
    Genet Med; 2009 May; 11(5):372. PubMed ID: 19346956
    [No Abstract]   [Full Text] [Related]  

  • 28. [Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].
    Tümmler B; Stuhrmann M
    Internist (Berl); 2003 Jun; 44 Suppl 1():S7-15. PubMed ID: 14567084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis mutations in Romania.
    Popa I; Pop L; Popa Z; Schwarz MJ; Hambleton G; Malone GM; Haworth A; Super M
    Eur J Pediatr; 1997 Mar; 156(3):212-3. PubMed ID: 9083763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report on the p.Ser489X (p.Ser489*) CFTR mutation, a variant with severe associated phenotype and high prevalence in a Quebec French-Canadian cystic fibrosis patient population.
    De Bie I; Agatep R; Scott P; Ruchon A
    Genet Med; 2012 Oct; 14(10):883-6. PubMed ID: 22627569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimutational analysis of eleven cystic fibrosis mutations common in the Mediterranean areas.
    Farez-Vidal ME; Gómez-Llorente C; Blanco S; Morales P; Casals T; Gómez-Capilla JA
    Clin Chem; 2004 Nov; 50(11):2155-7. PubMed ID: 15502086
    [No Abstract]   [Full Text] [Related]  

  • 32. Four adult patients with the missense mutation L206W and a mild cystic fibrosis phenotype.
    Desgeorges M; Rodier M; Piot M; Demaille J; Claustres M
    Hum Genet; 1995 Dec; 96(6):717-20. PubMed ID: 8522333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis testing comes of age.
    Grody WW
    J Mol Diagn; 2009 May; 11(3):173-5. PubMed ID: 19359497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.
    Grody WW
    Genet Med; 2011 Dec; 13(12):996-7. PubMed ID: 22134443
    [No Abstract]   [Full Text] [Related]  

  • 36. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of atypical CF: a case-report to reflect.
    Alghisi F; Angioni A; Tomaiuolo AC; D'Apice MR; Bella S; Novelli G; Lucidi V
    J Cyst Fibros; 2008 Jul; 7(4):292-294. PubMed ID: 18180206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis screening: lessons learned from the first 320,000 patients.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Sun W
    Genet Med; 2004; 6(3):136-40. PubMed ID: 15354331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.